WEB 1881 FU Ameliorates Impairment of Working Memory Induced by Scopolamine and Cerebral Ischemia in the Three-Panel Runway Task

the japanese journal of pharmacology

Volumn 54, Issue 1, 1990, Pages 53-60

  Ohno, Masuo ^a   Yamamoto, Tsuneyuki ^a   Kitajima, Iwao ^a   Ueki, Showa ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIRACETAM; HOPANTENATE CALCIUM; NEBRACETAM FUMARATE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEMORY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMAL; BRAIN ISCHEMIA; COMPARATIVE STUDY; GAMMA-AMINOBUTYRIC ACID; MALE; MEMORY; MEMORY DISORDERS; PANTOTHENIC ACID; PARASYMPATHOLYTICS; PYRROLIDINONES; RATS; RATS, INBRED STRAINS; SCOPOLAMINE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0025090660     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.54.53     Document Type: Article

References (43)

1. Davies, P. and Maloney, A.J.F.: Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2, 1403 (1976)
2. Henke, H. and Lang, W.: Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Brain Res. 267, 281-291 (1983)
3. Perry, E.K., Gibson, P.H., Blessed, G., Perry, R.H. and Tomlinson, B.E.: Neurotransmitter enzyme abnormalities in senile dementia. J. Neurol. Sci. 34, 247-265 (1977)
4. Frumier, M.J., Herckar, V.R. and Jarvik, M.E.: Amnesic actions cf diazepam and scopolamine in man. Anesthesiology 45, 406-410 (1976)
5. Safer, D.J. and Allen, R.P.: The central effects of scopolamine in man. Biol. Psychiatry 3, 347-355 (1971)
6. Sitaram, N., Weingartner, H. and Gillin, J.C.: Human serial learning: Enhancement with arecholine and choline and impairment with scopolamine. Science 201, 274-276 (1978)
7. Dilts, S.L. and Berry, C.A.: Effect of cholinergic drugs on passive avoidance in the mouse. J. Pharmacol. Exp. Ther. 158, 279-285 (1967)
8. Higashida, A. and Ogawa, N.: Differences in the acquisition process and the effect of scopolamine on radial maze performance in three strains of rats. Pharmacol. Biochem. Behav. 27, 483-489 (1987)
9. Levin, E.D. and Bowman, R.E.: Scopolamine effects on Hamilton search task performance in monkeys. Pharmacol. Biochem. Behav. 24, 819-821 (1986)
10. Spangler, E.L., Rigby, P. and Ingram, D.K.:Scopolamine impairs learning performance of rats in a 14-unit T-maze. Pharmacol. Biochem. Behav. 25, 673-679 (1986)
11. Watts, J., Stevens, R. and Robinson, C.: Effects of scopolamine on radial maze performance in rats. Physiol. Behav. 26, 845-851 (1981)
12. Cummings, J.L., Tomiyasu, U., Read, S. and Benson, D.F.: Amnesia with hippocampal lesions after cardiopulmonary arrest. Neurology 34, 679-681 (1984)
13. Volpe, B.T. and Hirst, W.: The characterization of an amnesic syndrome following hypoxic ischemic injury. Arch. Neurol. 40, 436-440 (1983)
14. Pulsinelli, W.A. and Brierley, J.B.: A new model of bilateral hemispheric ischemia in the un-anesthetized rat. Stroke 10, 267-272 (1979)
15. Davis, H.P., Baranowski, J.R., Pulsinelli, W.A. and Volpe, B.T.: Retention of reference memory following ischemic hippocampal damage. Physiol. Behav. 39, 783-786 (1987)
16. Davis, H.P., Tribuna, J., Pulsinelli, W.A. and Volpe, B.T.: Reference and working memory of rats following hippocampaldamage induced by transient forebrain ischemia. Physiol. Behav. 37, 387-392 (1986)
17. Yamazaki, N., Take, Y., Nagaoka, A. and Nagawa, Y.: Beneficial effect of idebenone (CV-2619) on cerebral ischemia-induced amnesia in rats. Japan. J. Pharmacol. 36, 349-356 (1984)
18. Kakihana, M., Yamazaki, N. and Nagaoka, A.: Effects of idebenone (CV-2619) on the concentrations of acetylcholine and choline in various brain regions of rats with cerebral ischemia. Japan. J. Pharmacol. 36, 357-363 (1984)
19. Kitamura, Y., Hayashi, S. and Nomura, Y.: Effects of WEB 1881 FU, a novel nootropic, on cholinergic and adrenergic receptors in the rat brain: Action on M1-muscarinic receptors. Japan. J. Pharmacol. 52, 597-607 (1990)
20. Kuhn, F.J., Schingnitz, G., Lehr, E., Montagna, E., Hinzen, H.D. and Giachetti, A.: Pharmacology of WEB 1881 - FU, a central cholinergic agent, which enhances cognition and cerebral metabolism. Arch. Int. Pharmacodyn. Ther. 292, 13-34 (1988)
21. Honig, W.K.: Studies of working memory in the pigeon. In Cognitive Aspects in Animal Behavior, Edited by Hulse. S.H., Fowler, H. and Honig, W.K., p. 211-248, Lawrence Erlbaum, Hillsdale (1978)
22. Olton, D.S., Becker, J.T. and Handelmann, G.E.: Hippocampus, space, and memory. Behav. Brain Sci. 2, 313-365 (1979)
23. Olton, D.S. and Papas, B.C.: Spatial memory and hippocampal function. Neuropsychologia 17, 669-982 (1979)
24. Cumin, R., Bandle, E.F., Gamzu, E. and Haefely, W.E.: Effects of the novel compound aniracetam (Ro1 3-5057) upon impaired learning and memory in rodents. Psychopharmacology (Berlin) 78, 104-111 (1982)
25. Spignoli, G. and Pepeu, G.: Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine. Pharmacol. Biochem. Behav. 27, 491-495 (1987)
26. Takakura, K., Iwasaki, Y., Shitara, N., Iwasaki, A. and Fujiwara, M.: Spatial memory disturbance in hydrocephalus and the effect of drugs modifying neurotransmitters. In Neurotransmitters and Neuroreceptors, Edited by Kuriyama, K., p. 5665, Excerpta Medica, Amsterdam (1987)
27. Atarashi, J. and Otomo, E.: Clinical evaluation of HOPA (HOPATE®) in the treatment of cerebrovascular disorders Multi-center double-blind study in comparison with ifenprodil tartrate and placebo. Clin. Eval. 9, 673-710 (1981) (Abs.in English)
28. Mizuki, Y., Yamada, M., Kato, I., Takada, Y., Tsujimaru, S., Inanaga, K. and Tanaka, M.: Effects of aniracetam, a nootropic drug, in senile dementia-A preliminary report. Kurume Med. J. 31, 135-143 (1984)
29. Furuya, Y., Yamamoto, T., Yatsugi, S. and Ueki, S.: A new method for studying working memory by using the three-panel runway apparatus in rats. Japan. J. Pharmacol. 46, 183-188 (1988)
30. Yamamoto, T., Yatsugi, S., Ohno, M., Furuya, Y., Kitajima, I. and Ueki, S.: Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats. Psychopharmacology (Berlin) 100, 316-322 (1990)
31. Davis, K.L., Mohs, R.C., Tinklenberg, J.R., Pfefferbaum, A., Hollister, L.E. and Koppel, B.S.: Physostigmine: Improvement of long-term memory processes in normal humans. Science 201, 272-274 (1978)
32. Baratti, C.M., Huygens, P., Mino, J., Merlo, A. and Gardella, J.: Memory facilitation with post-trial injection of oxotremorine and physostigmine in mice. Psychopharmacology (Berlin) 64, 85-88 (1979)
33. Verloes, R., Scotto, A.-M., Gobert, J. and Wulfert, E.: Effects of nootropic drugs in a scopolamine-induced amnesia model in mice. Psychopharmacology (Berlin) 95, 226-230 (1988)
34. Caulfield, M.P., Higgins, G.A. and Straughan, D.W.: Central administration of the muscarinic receptor subtype-selectiveantagonist pirenzepine selectively impairs passive avoidance learning in the mouse. J. Pharm. Pharmacol. 35, 131-132 (1983)
35. Hagan, J.J., Jansen, J.H.M. and Broekkamp, C.L.E.: Blockade of spatial learning by the Mt muscarinic antagonist pirenzepine. Psychopharmacology (Berlin) 93, 470-476 (1987)
36. Hunter, A.J. and Roberts, F.F.: The effect of pirenzepine on spatial learning in the Morris water maze. Pharmacol. Biochem. Behav. 30, 519-523 (1988)
37. Nakahiro, M., Fujita, N., Fukuchi, I., Saito, K., Nishimura, T. and Yoshida, H.: Pantyl-γ-aminobutyric acid facilitates cholinergic function in the central nervous system. J. Pharmacol. Exp. Ther. 232, 501-506 (1985)
38. Nakahiro, M. and Yoshida, H.: The “antidementia drug” pantoyl-γ-aminobutyric acid increases high affinity uptake of choline by slices of rat brain. Neuropharmacology 25, 227-230 (1986)
39. Yamamoto, T., Yatsugi, S., Ohno, M. and Ueki, S.: Effect of amiridin and tetrahydroaminoacridine (THA) upon impaired working memory in rats. Japan. J. Pharmacol. Supp. 46, 166P (1988)
40. Gibson, G.E. and Blass, J.P.: Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J. Neurochem. 27, 37-42 (1976)
41. Scremin, A.M.E. and Scremin, O.U.: Physostigmine-induced cerebral protection against hypoxia. Stroke 10, 142-143 (1979)
42. Ljunggren, B., Ratcheson, R.A. and Siesjo, B.K.: Cerebral metabolic state following complete compression ischemia. Brain Res. 73, 291-307 (1974)
43. Levy, D.E. and Duffy, T.E.: Cerebral energy metabolism during transient ischemia and recovery in the gerbil. J. Neurochem. 28, 63-70 (1977)